Drugs for HIV and AIDS trialed as brain tumor treatment for first time

Drugs developed to combat HIV and AIDS are being trialled for the first time in patients with multiple brain tumours.

Scientists at the Brain Tumour Research Centre of Excellence at the University of Plymouth are conducting a clinical trial to see whether using anti-retroviral medications, Ritonavir and Lopinavir, could help people with Neurofibromatosis 2 (NF2).

The rare inherited genetic condition causes tumours such as schwannoma (which include acoustic neuroma), ependymoma and meningioma which develop on the membrane surrounding the brain.

The RETREAT clinical trial, led by Professor Oliver Hanemann, will expand on research by Dr Sylwia Ammoun and Professor Hanemann which showed the repurposed drugs reduced tumour growth and survival in the tumours.